                         SEQUENCE LISTING

<110>  AFFIBODY AB
 
<120>  NEW POLYPEPTIDE

<130>  21131989

<150>  EP21157213.6
<151>  2021-02-15

<160>  6     

<170>  PatentIn version 3.5

<210>  1
<211>  59
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Engineered HER2 binding polypeptide

<400>  1

Ala Glu Ala Lys Tyr Ala Lys Glu Met Arg Asn Ala Tyr Trp Glu Ile 
1               5                   10                  15      


Ala Leu Leu Pro Asn Leu Thr Asn Gln Gln Lys Arg Ala Phe Ile Arg 
            20                  25                  30          


Lys Leu Tyr Asp Asp Pro Ser Gln Ser Ser Glu Leu Leu Ser Glu Ala 
        35                  40                  45              


Lys Lys Leu Ser Glu Ser Gln Gly Gly Gly Cys 
    50                  55                  


<210>  2
<211>  59
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Engineered HER2 binding polypeptide

<400>  2

Ala Glu Asn Lys Phe Asn Lys Glu Met Arg Asn Ala Tyr Trp Glu Ile 
1               5                   10                  15      


Ala Leu Leu Pro Asn Leu Thr Asn Gln Gln Lys Arg Ala Phe Ile Arg 
            20                  25                  30          


Ser Leu Tyr Asp Asp Pro Ser Gln Ser Ala Asn Leu Leu Ala Glu Ala 
        35                  40                  45              


Lys Lys Leu Asn Asp Ala Gln Gly Gly Gly Cys 
    50                  55                  


<210>  3
<211>  61
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Engineered HER2 binding polypeptide

<400>  3

Ala Glu Asn Lys Phe Asn Lys Glu Met Arg Asn Ala Tyr Trp Glu Ile 
1               5                   10                  15      


Ala Leu Leu Pro Asn Leu Thr Asn Gln Gln Lys Arg Ala Phe Ile Arg 
            20                  25                  30          


Ser Leu Tyr Asp Asp Pro Ser Gln Ser Ala Asn Leu Leu Ala Glu Ala 
        35                  40                  45              


Lys Lys Leu Asn Asp Ala Gln Ala Pro Lys Val Asp Cys 
    50                  55                  60      


<210>  4
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  C-terminal sequence in engineered polypeptide of e.g. Ahlgren et 
       al 2009

<400>  4

Lys Val Asp Cys 
1               


<210>  5
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  C-terminal sequence in engineered polypeptide of the disclosure

<400>  5

Gly Gly Gly Cys 
1               


<210>  6
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  N-terminal sequence in engineered polypeptide of e.g. Lindberg et
       al 2012

<400>  6

His Glu His Glu His Glu 
1               5       


